Exeltis

What Exeltis does

Exeltis S.A.S. is the Colombian subsidiary of Spanish multinational Insud Pharma, founded in Colombia in 2016 and headquartered in Bogotá. The company develops, markets, and distributes a portfolio of pharmaceutical products, dietary supplements, and medical devices focused exclusively on women's health across life stages — contraception (oral contraceptives and vaginal rings such as Slinda), pregnancy support (Bonjesta for nausea/vomiting, SMPS prenatal supplements), HPV and cervical health (Deflagyn medical device), endometriosis, menopause (Exelfem), and nutritional supplementation (ExelMyo, Exelageno, ExelGes-B). Its product offering is backed by 300+ SKUs and benefits from Insud Pharma group's 15 industrial plants, 10 R&D centers, and operations in 40+ countries.

The company operates a hybrid go-to-market model: prescription pharmaceuticals are driven through healthcare professional engagement targeting gynecologists, obstetricians, and general practitioners — supported by a credentialed Exeltis Medical Experience portal validated against Ministry of Health databases — while OTC dietary supplements and select products are sold directly through seven major Colombian pharmacy chains (Farmatodo, La Rebaja, Colsubsidio, Cruz Verde, Pasteur, Lopido, CAFAM) across both physical and online channels. By 2020, Exeltis reached #2 share in Colombia's prescription oral contraceptive market (advancing from #4 in 2019), and by 2022 had distributed 915,000 cumulative treatments to Colombian women. Patient education tools including the PUQE-24 nausea severity assessment, menopause quizzes, and disease-state content across HPV, endometriosis, and nutrients round out a content-marketing layer aimed at both consumers and HCPs.

Revenue is generated through one-time product sales across prescription and supplement lines, with no subscription, licensing, or platform recurring component. The Colombian entity operates as a wholly-owned subsidiary under the Insud Pharma group, with no disclosed external investors, debt, or equity funding events; the local team is lean (1–10 listed employees) and relies on group-level R&D, manufacturing, and brand infrastructure for product supply. Exeltis is led by Country Manager Adriana Cleves, and the company maintains active consumer-facing social media channels (Instagram, Facebook) alongside HCP-facing digital engagement.

Name

Exeltis

Legal name

Exeltis S.A.S.

Website

https://exeltiscolombia.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Exeltis S.A.S., the Colombian subsidiary of Spain's Insud Pharma, develops and distributes pharmaceutical products, dietary supplements, and medical devices exclusively for women's health across pregnancy, contraception, HPV, endometriosis, menopause, and nutrition, selling through major pharmacy chains and healthcare professionals in Colombia since 2016.

Ownership category

akta.pro rank

Product category

Women's Health Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK), Menstrual Pain Relief & Period Care Supplements (CRABAIAJ)

Keywords

• Women's health pharmaceuticals
• Oral contraceptives
• Prenatal supplements
• Menopausal therapy
• HPV medical devices

Headquarters

HQ city

Suba

HQ country

Colombia

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Pharmaceutical Products - Women's Health: Exeltis generates revenue through the sale of prescription and OTC pharmaceutical products focused on women's health including oral contraceptives, pregnancy supplements, endometriosis treatments, HPV management, and menopausal therapies. The company offers over 300 products for health and wellness.
2. Dietary Supplements: Sale of dietary supplements including Myo-Inositol formulations, iron supplements, complex B vitamins, collagen with biotin, vitamin D, and other micronutrients targeting women's health across life stages.

Pricing tiers

Go-to-market motion2 records

Distribution channels8 records

Marketing channels7 records

Core offering

Exeltis develops, manufactures, and markets prescription pharmaceuticals and over-the-counter dietary supplements focused exclusively on women's health, spanning pregnancy support, oral and vaginal contraception, HPV management, endometriosis, menopause, and nutritional supplementation. The Colombian operation sells a portfolio of more than 300 products through national pharmacy chains and via healthcare professional prescriptions, supported by an HCP-exclusive medical information portal.

Product overview

Exeltis is a multinational pharmaceutical company specializing in women's health, offering a portfolio of pharmaceutical products, dietary supplements, and medical devices. The product portfolio includes contraceptives (Slinda), pregnancy support products (Bonjesta), dietary supplements (ExelMyo, Exelageno, Exelfem, ExelGes-B), HPV-related medical devices (Deflagyn), and a healthcare professional portal (Exeltis Medical Experience). The company operates primarily in women's health across key life stages including pregnancy, contraception, and menopause, with operations in Colombia since 2016.

Differentiator

Problem solved

Functional benefit

Brands

• ExelMyo: Dietary supplement product for women's health
• Exelageno
• Exelfem
• ExelGes
• Bonjesta

Products and services

• Bonjesta Prescription pharmaceutical for managing nausea and vomiting during pregnancy (NVP), targeting pregnant women in Colombia.
• Slinda Oral contraceptive for family planning, prescribed to women in Colombia through gynecologists and pharmacists.
• Deflagyn Medical device for HPV (Human Papillomavirus) support and care, targeted at Colombian women requiring HPV coadjuvant management.
• ExelMyo Dietary supplement containing Myo-Inositol for hormonal balance and insulin sensitivity, marketed to women for PCOS and general women's wellness in Colombia.
• Exelageno Dietary supplement for women's health and wellness, distributed through Colombian pharmacy chains.
• Exelfem Dietary supplement supporting women's health across life stages, including menopause, distributed through Colombian pharmacies.
• ExelGes-B Dietary supplement supporting women's nutritional health, sold through Colombian pharmacy retail.

Quantifiable outcome

• Exeltis distributed 915,000 treatments to women in Colombia by 2022
• +3 more outcomes

Named customers4 records

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• FarmatodocoreChannel Partner/ Reseller/ DistributorMajor Colombian pharmacy chain serving as primary retail distribution channel for Exeltis dietary supplements and select products. Products available through both physical store locations and online ordering platform.
• La RebajacoreChannel Partner/ Reseller/ DistributorMajor Colombian pharmacy chain with extensive retail presence used for Exeltis product distribution across Colombia.
• ColsubsidiocoreChannel Partner/ Reseller/ DistributorColsubsidio pharmacy chain affiliated with Colombian social security system serving as distribution partner for Exeltis products.
• Cruz VerdecoreChannel Partner/ Reseller/ DistributorNational pharmacy chain with both retail and e-commerce presence distributing Exeltis products in Colombia.
• Farmacias PasteurminorChannel Partner/ Reseller/ DistributorRegional pharmacy chain in Colombia serving as distribution channel for Exeltis products.
• LopidominorChannel Partner/ Reseller/ DistributorOnline pharmacy platform enabling digital distribution of Exeltis products to consumers.
• CAFAMminorChannel Partner/ Reseller/ DistributorCAFAM pharmacy and wellness stores affiliated with Colombian teachers' pension fund serving as distribution channel.
• Insud Pharma (Parent Company)coreOthersExeltis is a subsidiary of Insud Pharma, a Spanish multinational pharmaceutical group. Exeltis was created through the evolution and sustained growth of Insud Pharma, benefiting from 40 years of experience, 15 manufacturing plants, 10 R&D centers, and presence in 40+ countries.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Organon: Spun off from Merck to focus on women's health, biosimilars, and established brands - operates a portfolio that overlaps head-to-head with Exeltis in contraception, fertility, and women's health across global and Latin American markets.
• HRA Pharma: Specialty women's health pharmaceutical company (now part of Perrigo) focusing on reproductive health, emergency contraception, and gynecological therapies - mirrors Exeltis's specialty-pharma model and category focus.
• Theramex: Women's health specialty pharmaceutical company offering contraception, menopause, and reproductive health products globally; most directly comparable to Exeltis given similar women's-health-only focus and reliance on HCP engagement.
• Gedeon Richter: European specialty pharmaceutical company with a dedicated women's health franchise (contraception, menopause, fertility); competes with Exeltis in similar therapeutic categories and has footprint across multiple Latin American countries.

Regional players

• Eurofarma: Latin American (Brazilian) pharmaceutical multinational with a broad women's health and supplement portfolio; competes with Exeltis in the regional Latin American market but with a different home-country footprint.
• Genomma Lab: Mexican-based Latin American pharmaceutical and consumer health company with women's health and supplement brands competing in retail pharmacy channels across the region, including Colombia.

Emerging players

• TherapeuticsMD: U.S.-focused women's health specialty pharma (menopause, reproductive health) - comparable scale and therapeutic focus but geographically concentrated in North America rather than Latin America.

Broad incumbents

• Abbott (Pharmaceuticals): Diversified healthcare incumbent with established women's health, prenatal nutrition, and contraceptive products marketed in Colombia; broader portfolio incumbent with significant share in prenatal supplements where Exeltis also competes.
• Bayer (Pharmaceuticals): Global pharmaceutical incumbent with a major women's health franchise (oral contraceptives like Yaz/Yasmin, IUDs, menopause); competes broadly with Exeltis in Colombia's contraceptive market from a much larger commercial and R&D base.
• Pfizer: Multinational incumbent with established women's health products and large-scale Colombian operations - represents deep-pocketed competition in both prescription women's health and consumer supplements via its portfolio breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/exeltiscolombia
• Instagraminstagram.com/exeltiscolombia
• LinkedInlinkedin.com/company/exeltis-colombia

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exeltis